| Dr Nicole R Klein, MD | |
|
18051 River Ave, Suite 104, Noblesville, IN 46062-7093 | |
| (317) 573-4370 | |
| (317) 819-0044 |
| Full Name | Dr Nicole R Klein |
|---|---|
| Gender | Female |
| Speciality | Otolaryngology |
| Experience | 27 Years |
| Location | 18051 River Ave, Noblesville, Indiana |
| Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1740347111 | NPI | - | NPPES |
| 040017759 | Other | IN | MEDICARE RAILROAD |
| 200380850 | Medicaid | IN |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207Y00000X | Otolaryngology | 01050069A (Indiana) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Riverview Health | Noblesville, IN | Hospital |
| Indiana University Health North Hospital | Carmel, IN | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Otolaryngology Associates Llc | 7810931409 | 50 |
News Archive
The multiple sclerosis risk sharing scheme is "a costly failure" and should not be continued, according to researchers on bmj.com today. They argue that the biggest losers are the other NHS patients who would otherwise have benefited from the money spent on the scheme, estimated to be around -50m per year since it was set up in 2002.
Experts are recommending that adolescents and some adults be vaccinated against whooping cough to help prevent infection and potential transmission to infants, according to the December 15 issue of Clinical Infectious Diseases, now available online.
The intestinal hormone secretin, considered by some to be a promising drug in the treatment of autism, does not improve the symptoms and should not be used to treat the disorder, according to a new review of studies.
Simcere Pharmaceutical Group, a leading pharmaceutical company specializing in the development, manufacturing, and marketing of branded and proprietary pharmaceuticals in China, today announced that the Company entered into a share transfer agreement with Devont Asset Management Limited on January 15th 2013 to sell an approximately 35% equity interest in Shanghai Celgen Bio-Pharmaceutical Co., Ltd. for a cash consideration of RMB 302 million.
Researchers demonstrated the success of a fully implantable wireless medical device, the Stentrode™ brain-computer interface (BCI), designed to allow patients with severe paralysis to resume daily tasks - including texting, emailing, shopping and banking online - without the need for open brain surgery.
› Verified 1 days ago
| Entity Name | Otolaryngology Associates Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1447398839 PECOS PAC ID: 7810931409 Enrollment ID: O20050614001395 |
News Archive
The multiple sclerosis risk sharing scheme is "a costly failure" and should not be continued, according to researchers on bmj.com today. They argue that the biggest losers are the other NHS patients who would otherwise have benefited from the money spent on the scheme, estimated to be around -50m per year since it was set up in 2002.
Experts are recommending that adolescents and some adults be vaccinated against whooping cough to help prevent infection and potential transmission to infants, according to the December 15 issue of Clinical Infectious Diseases, now available online.
The intestinal hormone secretin, considered by some to be a promising drug in the treatment of autism, does not improve the symptoms and should not be used to treat the disorder, according to a new review of studies.
Simcere Pharmaceutical Group, a leading pharmaceutical company specializing in the development, manufacturing, and marketing of branded and proprietary pharmaceuticals in China, today announced that the Company entered into a share transfer agreement with Devont Asset Management Limited on January 15th 2013 to sell an approximately 35% equity interest in Shanghai Celgen Bio-Pharmaceutical Co., Ltd. for a cash consideration of RMB 302 million.
Researchers demonstrated the success of a fully implantable wireless medical device, the Stentrode™ brain-computer interface (BCI), designed to allow patients with severe paralysis to resume daily tasks - including texting, emailing, shopping and banking online - without the need for open brain surgery.
› Verified 1 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Nicole R Klein, MD 9002 N Meridian St, Suite 222, Indianapolis, IN 46260-5350 Ph: (317) 819-4516 | Dr Nicole R Klein, MD 18051 River Ave, Suite 104, Noblesville, IN 46062-7093 Ph: (317) 573-4370 |
News Archive
The multiple sclerosis risk sharing scheme is "a costly failure" and should not be continued, according to researchers on bmj.com today. They argue that the biggest losers are the other NHS patients who would otherwise have benefited from the money spent on the scheme, estimated to be around -50m per year since it was set up in 2002.
Experts are recommending that adolescents and some adults be vaccinated against whooping cough to help prevent infection and potential transmission to infants, according to the December 15 issue of Clinical Infectious Diseases, now available online.
The intestinal hormone secretin, considered by some to be a promising drug in the treatment of autism, does not improve the symptoms and should not be used to treat the disorder, according to a new review of studies.
Simcere Pharmaceutical Group, a leading pharmaceutical company specializing in the development, manufacturing, and marketing of branded and proprietary pharmaceuticals in China, today announced that the Company entered into a share transfer agreement with Devont Asset Management Limited on January 15th 2013 to sell an approximately 35% equity interest in Shanghai Celgen Bio-Pharmaceutical Co., Ltd. for a cash consideration of RMB 302 million.
Researchers demonstrated the success of a fully implantable wireless medical device, the Stentrode™ brain-computer interface (BCI), designed to allow patients with severe paralysis to resume daily tasks - including texting, emailing, shopping and banking online - without the need for open brain surgery.
› Verified 1 days ago
Michael A Agostino, MD Otolaryngology Medicare: Accepting Medicare Assignments Practice Location: 18051 River Road, Suite 104, Noblesville, IN 46062 Phone: 317-844-7059 Fax: 317-819-0044 | |
David E Wilson, M.D. Otolaryngology Medicare: Not Enrolled in Medicare Practice Location: 18000 River Ave, Noblesville, IN 46062 Phone: 317-773-6579 Fax: 317-776-4557 | |
Samuel A Harmon, M.D. Otolaryngology Medicare: Accepting Medicare Assignments Practice Location: 18000 River Ave, Noblesville, IN 46062 Phone: 317-773-6579 Fax: 317-776-4557 | |
Matthew Bruns, M.D. Otolaryngology Medicare: Accepting Medicare Assignments Practice Location: 18000 River Ave, Noblesville, IN 46062 Phone: 317-773-6579 | |
Charlotte Marie Dugan, M.D. Otolaryngology Medicare: Accepting Medicare Assignments Practice Location: 18000 River Ave, Noblesville, IN 46062 Phone: 317-773-6579 Fax: 317-776-4557 |